Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein kinase C eta
(
nPKC
eta) is a member of the
protein kinase C
family with a unique tissue distribution in skin and lung. We analyzed
nPKC
eta expression in normal murine lung and in 36 lung tumors induced by urethane in AC3 F1 and F2 mice. The
nPKC
eta-related transcript was present at fivefold to tenfold lower levels in tumors than in normal lung controls. We mapped two distinct loci for
nPKC
eta on murine chromosome 12, using linkage analysis in an interspecific test cross. The results indicate that the mouse Pkcn-rs1 and Pkcn-rs2 loci were about 30 cM from the centromere and about 2 cM from each other.
...
PMID:Expression in lung tumors and genetic mapping of the novel murine protein kinase C eta. 814 15
The mammary gland has the ability to undergo repeated cycles of tightly regulated postnatal proliferation, differentiation, and apoptosis-mediated regression, providing a model to investigate potential regulators of mammary epithelial growth and differentiation.
Protein kinase C eta
is a candidate regulator of mammary epithelial differentiation, as increased expression of
PKC
eta is often observed during the terminal differentiation of many epithelial tissues. In this study,
PKC
eta expression and localization were characterized during puberty, pregnancy, lactation and involution in isolated rat mammary epithelial cells (MEC), as well as in paraffin-embedded and frozen rat mammary gland sections. By Western blot analysis of whole cell lysates from purified MEC,
PKC
eta protein expression increased during the shift from resting to a pregnant state. This increased
PKC
eta protein expression during pregnancy was associated with alveolar rather than ductal development, as immunohistochemical staining for
PKC
eta was increased in differentiating secretory alveoli, but not ducts. By immunofluorescent staining,
PKC
eta was stained intensely in an intracellular reticular meshwork throughout the cytosol of alveolar epithelial cells from pregnant mammary gland. During lactation,
PKC
eta was abundant in apocrine bodies budding from the alveolar epithelium, in the lumen of alveoli, and was present in milk, in association with casein, while being decreased in the cytoplasm of the luminal alveolar epithelium. Staining intensity of alveoli for
PKC
eta decreased further during involution. Western blotting of subcellular fractions from isolated mammary epithelial cells demonstrated that
PKC
eta remained associated with the membrane and particulate fractions throughout development. The upregulation of
PKC
eta in alveolar but not ductal epithelium during pregnancy suggests an association with functional secretory differentiation.
...
PMID:Protein kinase C eta upregulation and secretion during postnatal rat mammary gland differentiation. 980 88
Protein kinase C eta
(PKCeta) is one of several
PKC
isoforms found in humans. It is a novel
PKC
isoform in that it is activated by diacylglycerol and anionic phospholipids but not calcium. The crystal structure of the PKCeta-C2 domain, which is thought to mediate anionic phospholipid sensing in the protein, was determined at 1.75 A resolution. The structure is similar to that of the
PKC
epsilon C2 domain but with significant variations at the putative lipid-binding site. Two serine residues within
PKC
eta were identified in vitro as potential autophosphorylation sites. In the unphosphorylated structure both serines line the putative lipid-binding site and may therefore play a role in the lipid-regulation of the kinase.
...
PMID:Structure of human protein kinase C eta (PKCeta) C2 domain and identification of phosphorylation sites. 1697 27